Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksChesnara Regulatory News (CSN)

Share Price Information for Chesnara (CSN)

Share Price is delayed by 15 minutes
Get Live Data
334.00    -1.50 (-0.45%)
Bid:
333.50
Ask:
334.50
Spread: 1.00 (0.30%)
Market Cap: £770.43m
CSN Live PriceLast checked at - London Stock Exchange

Intraday Chesnara Share Chart

Directorate Change

14 Feb 2022 07:00

RNS Number : 4988B
Chesnara PLC
14 February 2022
 

CHESNARA plc

("Chesnara" or "the Company")

 

14 February 2022

 

LEI Number: 213800VFRMBRTSZ3SJ06

 

 

INDEPENDENT NED APPOINTMENTS

 

Chesnara plc today announces the appointment of two new independent Non-Executive Directors, Carol Hagh and Karin Bergstein, to the Board with immediate effect. They will be proposed for election at the Company's AGM on 17 May 2022.

 

Carol will join Chesnara plc Nomination & Governance Committee and Remuneration Committee with Karin joining Chesnara plc Audit & Risk Committee and Nomination & Governance Committee.

 

Carol has had an extensive international career in the insurance sector. She was previously head of the UK insurance practice at the executive search firm Spencer Stuart. Prior to this, she held roles in strategy, customer centricity and digital innovation at Aviva in the UK and Aegon in the Netherlands. She began her career in the US as an actuarial trainee. Carol holds a BA from Harvard University and an MBA from INSEAD.

 

Karin brings a wealth of experience from a career in executive and non-executive roles. She has helped a number of listed companies develop and grow with a proven track record in M&A and (digital) transformation. Most recently these have included roles as CFO for Aidence N.V., COO of a.s.r. Nederland N.V. and various senior executive positions within ING Bank and its subsidiaries. Karin is also an experienced non-executive in financial services (BNG Bank N.V, Van Lanschot Kempen N.V.), care / pharma (Sanquin) and academic (Utrecht University) environments. Karin holds a number of undergraduate and post-graduate qualifications from institutions in the Netherlands, US and France.

 

Their appointments increase the total number of Board Directors at Chesnara, to six from five prior to the retirement of Veronica Oak in January.

 

Chairman Luke Savage commented:

'I am delighted to welcome both Carol and Karin to the Board of Chesnara. We are delighted to have attracted two highly talented individuals with such diverse expertise and experience. Their insight and skills, particularly from an international perspective, will be of significant benefit to the Group as we continue to execute on our ambitious strategy and deliver value to our policyholders and shareholders.'

 

There is no further information relating to either Carol or Karin which would require disclosure under 9.6.13R of the Listing Rules.

 

For further information, please contact:

 

 

Roddy Watt

Director, Capital Markets

FWD

Forward thinking communications

 

T - 020 7280 0651

E - roddy.watt@fwdconsulting.co.uk 

 

 

Notes to Editors

Chesnara is a life and pensions company listed on the London Stock Exchange. It administers approximately 900,000 policies and operates as Countrywide Assured in the UK, as The Waard Group and Scildon in the Netherlands, and as Movestic in Sweden.

 

Following a three-pillar strategy, Chesnara's primary responsibility is the efficient administration of its customers' life and savings policies, ensuring good customer outcomes and providing a secure and compliant environment to protect policyholder interests. It also adds value by writing profitable new business in Sweden and the Netherlands and by undertaking value-adding acquisitions of either companies or portfolios.

 

Consistent delivery of the Company strategy has enabled Chesnara to increase its dividend for 17 years in succession.

 

Further details are available on the Company's website (www.chesnara.co.uk).

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOATBMRTMTJBBMT
Date   Source Headline
13th May 20251:00 pmRNSSenior Independent Director Appointment
13th May 202512:44 pmRNSAGM Statement
1st May 20257:00 amRNSTotal Voting Rights
25th Apr 20257:00 amRNSBlock listing Interim Review
24th Apr 20257:00 amRNSDirector/PDMR Shareholding
10th Apr 20257:00 amRNSNotice of AGM
7th Apr 202512:30 pmRNSApplication for Block Listing - Replacement
7th Apr 202512:09 pmRNSDirector/PDMR Shareholding
4th Apr 202512:00 pmRNSApplication for Block Listing
1st Apr 20257:00 amRNSTotal Voting Rights
31st Mar 20257:00 amRNSDirector/PDMR Shareholding
28th Mar 20252:45 pmRNSDirector/PDMR Shareholding
27th Mar 20257:00 amRNSFinal Results
10th Mar 20251:41 pmRNSNotice of Results (Replacement)
10th Mar 20257:00 amRNSNotice of Results
30th Jan 20259:07 amRNSDirector/PDMR Shareholding
29th Jan 20257:00 amRNSDirectorate Changes
23rd Dec 20247:00 amRNSAcquisition
12th Dec 202412:00 pmRNSDirector/PDMR Shareholding
22nd Nov 20241:55 pmRNSDirector/PDMR Shareholding
14th Nov 20242:06 pmRNSDirector/PDMR Shareholding
29th Oct 20247:00 amRNSDirector/PDMR Shareholding
25th Oct 20247:00 amRNSBlock listing Interim Review
11th Sep 20247:00 amRNSDirector/PDMR Shareholding
10th Sep 20247:00 amRNSHalf-year Report
12th Aug 20249:00 amRNSNotice of Half Year Results
1st Aug 20247:00 amRNSDirector/PDMR Shareholding
18th Jul 20249:00 amRNSExternal Directorship
10th Jul 20249:00 amRNSHolding(s) in Company
7th Jun 202411:28 amRNSDirector/PDMR Shareholding
6th Jun 20243:30 pmEQSHardman Talks Video | Chesnara plc (CSN) Management Presentation and Q&A
16th May 20247:00 amRNSDirector/PDMR Shareholding
14th May 20242:15 pmRNSAGM Statement
9th May 20242:04 pmEQSQ&A on Chesnara plc (CSN): Growth and stability insights
30th Apr 20244:45 pmRNSDirector/PDMR Shareholding
26th Apr 20244:57 pmRNSDirector/PDMR Shareholding
25th Apr 202410:00 amRNSBlock listing Interim Review
17th Apr 202410:00 amRNSNotice of AGM
16th Apr 20241:00 pmRNSDirector/PDMR Shareholding
15th Apr 20247:00 amRNSDirectorate Change
11th Apr 202410:23 amEQSHardman & Co Research on Chesnara plc (CSN): Good 2023 results set platform for future progress
9th Apr 20244:58 pmRNSDirectorate Change
4th Apr 20247:00 amRNSDirector/PDMR Shareholding
3rd Apr 20241:33 pmRNSDirector/PDMR Shareholding
28th Mar 202412:00 pmRNSTotal Voting Rights
28th Mar 20247:00 amRNSFinal Results
21st Mar 20247:45 amRNSDirector Declaration
14th Mar 202411:15 amRNSNotice of Results
29th Dec 202311:55 amRNSTotal Voting Rights
29th Dec 202311:50 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.